On the date of submission (April 22, 2024), SDKI Inc. (Headquarters: Shibuya-ku, Tokyo) conducted a study on the “Allergy Treatment Market” covering the forecast period of 2024 and 2036.
Detailed insights of the market research report are available at:
https://www.sdki.jp/reports/allergy-treatment-market/115211
Survey results announcement date: April 22, 2024
Researcher: SDKI Inc.
Research Scope: Our analysts conducted research on 551 market players. The players surveyed varied in size.
Study locations: North America (United States and Canada), Latin America (Mexico, Argentina, Rest of Latin America), Asia Pacific (Japan, China, India, Vietnam, Taiwan, Indonesia, Malaysia, Australia, Rest of Asia Pacific), Europe ( UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe), and Middle East & Africa (Israel, GCC countries, North Africa, South Africa, Rest of Middle East & Africa)
Survey method: 223 on-site surveys, 328 internet surveys
Survey period: February 2024 – March 2024
Key Takeaways: The study includes a market dynamics study of the Allergy Treatments market, including growth factors, challenges, opportunities, and recent market trends. Additionally, a detailed competitive analysis of key players in the market has been analyzed in this study. Market research also includes market segmentation and regional analysis (Japan and Global).
market snapshot
According to SDKI’s analytical research analysis, the allergy treatment market size was recorded at approximately USD 22.1 billion in 2023, and the market revenue is projected to reach approximately USD 51.4 billion by 2036. Moreover, the market is poised to grow at a CAGR of approximately 6.7% during the forecast period.
Global market overview for allergy treatment
Market overview
According to SDKI Inc.’s Allergy Treatment market research analysis, the market is expected to grow significantly due to the rising prevalence of allergic diseases in the elderly. According to the World Health Organization, the proportion of the world’s population aged 60 and over is expected to increase from 12% to 22% between 2015 and 2050. The aging body experiences changes in immune function and over time can develop new sensitivities, leading to the onset or worsening of allergic symptoms. Additionally, older adults often have multiple chronic health conditions, making allergy management more complex and requiring an individualized treatment approach. This demographic trend highlights the growing demand for professional allergy treatments and services, driving further growth in the allergy treatment market.
However, our current analysis and forecast of the allergy treatment market suggests that allergy treatments, perhaps even new and improved treatments such as biologics and immunotherapies, can be costly. . The high costs of these procedures can be difficult for patients to obtain. These challenges are most important for uninsured and economically underserved patients. Therefore, challenges in market growth and reaching people in need of allergy treatments may be driven by affordability barriers.
the latest news
Our research shows that there has been little recent development in the allergy treatment industry. these are:
• In February 2024, FDA announced that Xolair (omalizumab) for immunoglobulin E–E medicated food allergies in certain adults and children with 1 or more ear ) approved the injection.
• December 2023, Bristol – Myers Squibb KK announces marketing approval for an additional indication of Abecma.
market segmentation
Our Allergy Treatments market research segments the market based on route of administration into oral, inhaled, intranasal, and other. Oral is expected to hold the largest share during the forecast period. Oral medications stand out as a convenient and accessible treatment option, allowing flexibility in drug administration without time or location constraints, ultimately facilitating improved treatment adherence. This property is particularly beneficial for pediatric and elderly patients who may struggle with more complex administration techniques such as nasal sprays and inhalers, as well as individuals with limited manual dexterity or cognitive abilities. The overall mean ± SD score was 4.31 ± 1.625 before the intervention and 9.84 ± 1.699 after the intervention. After the intervention, the proportion of patients who used the nasal spray appropriately increased by 50.27%. Given their wide applicability to diverse patient populations, the demand for oral medications in the allergy treatment market is expected to surge significantly.
Regional overview
According to our allergy treatment market insights, Europe is expected to grow during the forecast period. The prevalence of allergies, including respiratory, food, and skin allergies, is increasing across Europe due to factors such as environmental change, urbanization, and dietary changes. Europe benefits from a mature market with high awareness of allergic diseases, increasing demand for innovative treatments and medical devices such as immunotherapies, auto-injectors and inhalers.
Japan boasts an advanced healthcare system with widespread access to medical facilities and advanced medical technology. This allows efficient diagnosis and treatment of allergies, increasing the demand for allergy treatments among both patients and healthcare professionals.
Key players in the allergy treatment market
As mentioned in our research report, the most prominent players in the global Allergy Treatment market are:
• Johnson & Johnson Services, Inc.
• Bayer AG
• Abbott.
• Merck & Co., Inc.
• Spirit Pharmaceuticals LLC.
In addition to this, the top 5 players in the Japanese market are:
• Sanofi
• DAIICHI SANKYO COMPANY, LIMITED.
• Takeda Pharmaceutical Company Limited.
• Eisai Co., Ltd.
• Astellas Pharma Inc.
free sample
You can request a free sample of this report here. https://www.sdki.jp/sample-request-115211
Company Profile:
SDKI’s goal is to provide trusted and in-depth market research and insights. We not only focus on researching and providing detailed market reports on growth indicators, challenges, trends, and competitive landscape, but also on completely transforming your business for maximum growth and success. I have placed Our market research analysts have years of experience working with companies of all sizes in a variety of industries and market sectors.
Contact Information-
Contact form: https://www.sdki.jp/contact/
Phone number: +81 50 50509337 (900-18:00) (excluding weekends and holidays)
URL: https://www.sdki.jp/
Tags: Allergy Treatment Market Development Trends Demand Growth Analysis Forecast NEWSCAST
-
